Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders

✍ Scribed by Robert A. Hodgson; Paul J. Bedard; Geoffrey B. Varty; Tatiana M. Kazdoba; Therese Di Paolo; Michael E. Grzelak; Annamarie J. Pond; Abdallah HadjTahar; Nancy Belanger; Laurent Gregoire; Aurelie Dare; Bernard R. Neustadt; Andrew W. Stamford; John C. Hunter

• Book ID: 118441379
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 484 KB
• Volume: 225
• Category: Article
• ISSN: 0014-4886
• DOI: 10.1016/j.expneurol.2010.07.011